Saint Lucia

Saint Lucia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.58 (0.47 - 0.68) 2019 Modelled IHME
0.58 (0.48 - 0.68) 2018 Modelled IHME
0.59 (0.49 - 0.68) 2017 Modelled IHME
0.59 (0.50 - 0.69) 2016 Modelled IHME
0.6 (0.51 - 0.70) 2015 Modelled IHME
0.61 (0.52 - 0.71) 2014 Modelled IHME
0.62 (0.52 - 0.72) 2013 Modelled IHME
0.63 (0.53 - 0.73) 2012 Modelled IHME
0.64 (0.53 - 0.75) 2011 Modelled IHME
0.65 (0.53 - 0.76) 2010 Modelled IHME
0.66 (0.54 - 0.77) 2009 Modelled IHME
0.66 (0.55 - 0.78) 2008 Modelled IHME
0.67 (0.56 - 0.79) 2007 Modelled IHME
0.67 (0.57 - 0.79) 2006 Modelled IHME
0.68 (0.57 - 0.80) 2005 Modelled IHME
0.68 (0.57 - 0.80) 2004 Modelled IHME
0.68 (0.56 - 0.80) 2003 Modelled IHME
0.68 (0.56 - 0.79) 2002 Modelled IHME
0.68 (0.56 - 0.80) 2001 Modelled IHME
0.69 (0.56 - 0.80) 2000 Modelled IHME
0.69 (0.56 - 0.81) 1999 Modelled IHME
0.7 (0.57 - 0.82) 1998 Modelled IHME
0.71 (0.57 - 0.84) 1997 Modelled IHME
0.71 (0.58 - 0.85) 1996 Modelled IHME
0.72 (0.58 - 0.86) 1995 Modelled IHME
0.72 (0.58 - 0.86) 1994 Modelled IHME
0.72 (0.58 - 0.86) 1993 Modelled IHME
0.72 (0.58 - 0.85) 1992 Modelled IHME
0.71 (0.58 - 0.85) 1991 Modelled IHME
0.71 (0.58 - 0.84) 1990 Modelled IHME
1.25 (0.14 - 9.19) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.05 (0.04 - 0.07) 2019 Modelled IHME
0.06 (0.04 - 0.07) 2018 Modelled IHME
0.06 (0.04 - 0.07) 2017 Modelled IHME
0.05 (0.03 - 0.06) 2016 Modelled IHME
0.04 (0.03 - 0.05) 2015 Modelled IHME
0.04 (0.03 - 0.05) 2014 Modelled IHME
0.04 (0.03 - 0.05) 2013 Modelled IHME
0.04 (0.03 - 0.06) 2012 Modelled IHME
0.04 (0.03 - 0.06) 2011 Modelled IHME
0.05 (0.03 - 0.06) 2010 Modelled IHME
0.05 (0.03 - 0.07) 2009 Modelled IHME
0.05 (0.04 - 0.07) 2008 Modelled IHME
0.05 (0.04 - 0.07) 2007 Modelled IHME
0.06 (0.04 - 0.08) 2006 Modelled IHME
0.06 (0.04 - 0.09) 2005 Modelled IHME
0.1 (0.07 - 0.12) 2004 Modelled IHME
0.16 (0.11 - 0.21) 2003 Modelled IHME
0.24 (0.17 - 0.31) 2002 Modelled IHME
0.3 (0.21 - 0.40) 2001 Modelled IHME
0.34 (0.24 - 0.45) 2000 Modelled IHME
0.35 (0.24 - 0.47) 1999 Modelled IHME
0.36 (0.25 - 0.48) 1998 Modelled IHME
0.36 (0.25 - 0.50) 1997 Modelled IHME
0.37 (0.25 - 0.51) 1996 Modelled IHME
0.37 (0.25 - 0.51) 1995 Modelled IHME
0.37 (0.26 - 0.51) 1994 Modelled IHME
0.37 (0.26 - 0.50) 1993 Modelled IHME
0.37 (0.26 - 0.50) 1992 Modelled IHME
0.37 (0.26 - 0.50) 1991 Modelled IHME
0.37 (0.26 - 0.50) 1990 Modelled IHME
0.39 (0.05 - 3.17) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
24 (18 - 32) 2019 Modelled IHME
25 (18 - 33) 2018 Modelled IHME
25 (18 - 33) 2017 Modelled IHME
25 (18 - 33) 2016 Modelled IHME
25 (19 - 33) 2015 Modelled IHME
25 (19 - 34) 2014 Modelled IHME
26 (19 - 34) 2013 Modelled IHME
27 (20 - 35) 2012 Modelled IHME
27 (20 - 35) 2011 Modelled IHME
27 (20 - 35) 2010 Modelled IHME
27 (20 - 35) 2009 Modelled IHME
27 (20 - 35) 2008 Modelled IHME
26 (20 - 35) 2007 Modelled IHME
26 (19 - 34) 2006 Modelled IHME
26 (19 - 34) 2005 Modelled IHME
26 (19 - 34) 2004 Modelled IHME
26 (19 - 34) 2003 Modelled IHME
26 (19 - 34) 2002 Modelled IHME
26 (20 - 34) 2001 Modelled IHME
26 (20 - 35) 2000 Modelled IHME
26 (20 - 35) 1999 Modelled IHME
26 (20 - 35) 1998 Modelled IHME
26 (20 - 35) 1997 Modelled IHME
26 (20 - 34) 1996 Modelled IHME
26 (20 - 35) 1995 Modelled IHME
26 (20 - 34) 1994 Modelled IHME
26 (20 - 34) 1993 Modelled IHME
26 (20 - 34) 1992 Modelled IHME
26 (20 - 35) 1991 Modelled IHME
26 (20 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
17 2018 Survey/reported WHO/UNICEF
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
95 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
85 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
91 2004 Survey/reported WHO/UNICEF
84 2003 Survey/reported WHO/UNICEF
14 2002 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.02 (1.63 - 2.50) 2019 Modelled IHME
1.99 (1.62 - 2.46) 2018 Modelled IHME
1.97 (1.59 - 2.43) 2017 Modelled IHME
1.94 (1.58 - 2.39) 2016 Modelled IHME
1.91 (1.54 - 2.36) 2015 Modelled IHME
1.88 (1.53 - 2.32) 2014 Modelled IHME
1.86 (1.51 - 2.30) 2013 Modelled IHME
1.84 (1.49 - 2.27) 2012 Modelled IHME
1.82 (1.47 - 2.25) 2011 Modelled IHME
1.8 (1.45 - 2.25) 2010 Modelled IHME
1.79 (1.44 - 2.23) 2009 Modelled IHME
1.77 (1.43 - 2.21) 2008 Modelled IHME
1.76 (1.42 - 2.19) 2007 Modelled IHME
1.75 (1.42 - 2.18) 2006 Modelled IHME
1.74 (1.41 - 2.18) 2005 Modelled IHME
1.74 (1.41 - 2.18) 2004 Modelled IHME
1.75 (1.41 - 2.18) 2003 Modelled IHME
1.75 (1.41 - 2.19) 2002 Modelled IHME
1.76 (1.42 - 2.20) 2001 Modelled IHME
1.77 (1.42 - 2.21) 2000 Modelled IHME
1.79 (1.44 - 2.22) 1999 Modelled IHME
1.81 (1.46 - 2.25) 1998 Modelled IHME
1.85 (1.48 - 2.30) 1997 Modelled IHME
1.87 (1.49 - 2.34) 1996 Modelled IHME
1.89 (1.51 - 2.37) 1995 Modelled IHME
1.9 (1.52 - 2.37) 1994 Modelled IHME
1.91 (1.54 - 2.38) 1993 Modelled IHME
1.92 (1.55 - 2.41) 1992 Modelled IHME
1.93 (1.55 - 2.41) 1991 Modelled IHME
1.93 (1.56 - 2.42) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
22 (15 - 29) 2019 Modelled IHME
22 (15 - 29) 2018 Modelled IHME
22 (15 - 29) 2017 Modelled IHME
22 (15 - 29) 2016 Modelled IHME
22 (15 - 28) 2015 Modelled IHME
21 (15 - 28) 2014 Modelled IHME
21 (15 - 28) 2013 Modelled IHME
21 (15 - 28) 2012 Modelled IHME
21 (15 - 28) 2011 Modelled IHME
21 (14 - 28) 2010 Modelled IHME
21 (14 - 28) 2009 Modelled IHME
21 (15 - 28) 2008 Modelled IHME
21 (15 - 28) 2007 Modelled IHME
21 (15 - 28) 2006 Modelled IHME
21 (15 - 29) 2005 Modelled IHME
21 (15 - 29) 2004 Modelled IHME
21 (15 - 28) 2003 Modelled IHME
22 (15 - 29) 2002 Modelled IHME
22 (15 - 28) 2001 Modelled IHME
22 (15 - 29) 2000 Modelled IHME
22 (15 - 29) 1999 Modelled IHME
22 (15 - 29) 1998 Modelled IHME
22 (15 - 29) 1997 Modelled IHME
22 (15 - 29) 1996 Modelled IHME
22 (15 - 30) 1995 Modelled IHME
22 (16 - 30) 1994 Modelled IHME
23 (16 - 30) 1993 Modelled IHME
23 (16 - 30) 1992 Modelled IHME
23 (16 - 30) 1991 Modelled IHME
23 (16 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.58 (%)
2019
(0.47 - 0.68(%))
IHME
HCV (RNA/cAg+)
2.02 (%)
2019
(1.63 - 2.5(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3
2019
(3 - 5)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
7
2019
(5 - 10)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.05 (%)
2019, latest modelled
(0.04 - 0.07(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
17 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines